BIO-RAD LABORATORIES, INC. (BIO-B) › Operating Cash FlowBIO-RAD LABORATORIES, INC. (BIO-B) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2008: $191.37M2009: $325.07M2010: $225.91M2011: $262.74M2012: $266.48M2013: $169.14M2014: $273.31M2015: $186.21M2016: $216.07M2017: $104.14M2018: $285.49M2019: $457.90M2020: $584.97M2021: $669.46M2022: $194.40M2023: $374.90M2024: $455.20M2025: $532.20M$532.20M2008Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025$532.20M+16.9%2024$455.20M+21.4%2023$374.90M+92.8%2022$194.40M-71.0%2021$669.46M+14.4%2020$584.97M+27.8%2019$457.90M+60.4%2018$285.49M+174.2%2017$104.14M-51.8%2016$216.07M+16.0%2015$186.21M-31.9%2014$273.31M+61.6%2013$169.14M-36.5%2012$266.48M+1.4%2011$262.74M+16.3%2010$225.91M-30.5%2009$325.07M+69.9%2008$191.37M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share